Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide vs. Biphasic Insulin Aspart 30 in Type 2 Diabetes
NCT02449603Phase 4Completed
- Sponsor
- Xijing Hospital
- Start
- Nov 2015
- Primary completion
- Apr 2018
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of exenatide in type 2 diabetes mellitus (T2DM), sponsored by Xijing Hospital. Started Nov 2015; status: completed.
02
Drugs
exenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02449603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02449603.